메뉴 건너뛰기
Diabetes
Volumn 62, Issue 10, 2013, Pages
Comment on: Selvin et al. sRAGE and risk of diabetes, cardiovascular disease, and death. Diabetes 2013; 62:2116-2121
Author keywords

[No Author keywords available]
Indexed keywords

ADAM10 ENDOPEPTIDASE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; GELATINASE B; IMMUNOGLOBULIN RECEPTOR;
EID: 84891552291     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1031     Document Type: Letter
Times cited : (3)
References (6)
  • 1
    • 84878236157 scopus 로고    scopus 로고
    • SRAGE and risk of diabetes, cardiovascular disease, and death
    • Selvin E, Halushka MK, Rawlings AM, et al. sRAGE and risk of diabetes, cardiovascular disease, and death. Diabetes 2013;62:2116-2121
    • (2013) Diabetes , vol.62 , pp. 2116-2121
    • Selvin, E.1    Halushka, M.K.2    Rawlings, A.M.3
  • 2
    • 77955347413 scopus 로고    scopus 로고
    • Higher plasma soluble receptor for advanced glycation end products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: A 12-year follow-up study
    • Nin JW, Jorsal A, Ferreira I, et al. Higher plasma soluble receptor for advanced glycation end products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Diabetes 2010;59:2027-2032
    • (2010) Diabetes , vol.59 , pp. 2027-2032
    • Nin, J.W.1    Jorsal, A.2    Ferreira, I.3
  • 3
    • 80054109172 scopus 로고    scopus 로고
    • Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes
    • FinnDiane Study Group
    • Thomas MC, Söderlund J, Lehto M, et al.; FinnDiane Study Group. Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes. Diabetologia 2011;54:2669-2677
    • (2011) Diabetologia , vol.54 , pp. 2669-2677
    • Thomas, M.C.1    Söderlund, J.2    Lehto, M.3
  • 4
    • 80052885987 scopus 로고    scopus 로고
    • Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: An analysis from the CARDS trial
    • Colhoun HM, Betteridge DJ, Durrington P, et al. Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial. Diabetes 2011;60:2379-2385
    • (2011) Diabetes , vol.60 , pp. 2379-2385
    • Colhoun, H.M.1    Betteridge, D.J.2    Durrington, P.3
  • 5
    • 84875052018 scopus 로고    scopus 로고
    • Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes
    • Fujisawa K, Katakami N, Kaneto H, et al. Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes. Atherosclerosis 2013;227:425-428
    • (2013) Atherosclerosis , vol.227 , pp. 425-428
    • Fujisawa, K.1    Katakami, N.2    Kaneto, H.3
  • 6
    • 73249144472 scopus 로고    scopus 로고
    • Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels
    • Gaens KH, Ferreira I, van der Kallen CJ, et al. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels. J Clin Endocrinol Metab 2009;94:5174-5180
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 5174-5180
    • Gaens, K.H.1    Ferreira, I.2    Van Der Kallen, C.J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.